Streamline Health® Reports Third Quarter 2020 Revenues of $2.6 million; ($1.1 million) Net Loss; Adjusted EBITDA ($0.7 million) Read more about Streamline Health® Reports Third Quarter 2020 Revenues of $2.6 million; ($1.1 million) Net Loss; Adjusted EBITDA ($0.7 million)
Streamline Health® To Report Third Quarter 2020 Financial Performance on December 8, 2020 Read more about Streamline Health® To Report Third Quarter 2020 Financial Performance on December 8, 2020
Streamline Health® Expands Reseller Agreement with Allscripts to include eValuator™ and CDI Solutions Read more about Streamline Health® Expands Reseller Agreement with Allscripts to include eValuator™ and CDI Solutions
Streamline Health(R) to Present at The MicroCap Best Ideas Conference, October 13, 2020 Read more about Streamline Health(R) to Present at The MicroCap Best Ideas Conference, October 13, 2020
Streamline Health® Reports Second Quarter 2020 Revenues of $2.9 million; ($1.1 million) Net Loss; Adjusted EBITDA ($0.4 million) Read more about Streamline Health® Reports Second Quarter 2020 Revenues of $2.9 million; ($1.1 million) Net Loss; Adjusted EBITDA ($0.4 million)
Large Mid-Atlantic Health System Signs New Contract for Streamline Health® eValuator™ Read more about Large Mid-Atlantic Health System Signs New Contract for Streamline Health® eValuator™
Streamline Health® To Report Second Quarter 2020 Financial Performance on September 9, 2020 Read more about Streamline Health® To Report Second Quarter 2020 Financial Performance on September 9, 2020
LARGE MIDWEST ACADEMIC MEDICAL CENTER SIGNS NEW CONTRACT FOR STREAMLINE HEALTH® eVALUATOR™ Read more about LARGE MIDWEST ACADEMIC MEDICAL CENTER SIGNS NEW CONTRACT FOR STREAMLINE HEALTH® eVALUATOR™
MID ATLANTIC ACADEMIC HOSPITAL SIGNS NEW CONTRACT FOR STREAMLINE HEALTH® eVALUATOR™ Read more about MID ATLANTIC ACADEMIC HOSPITAL SIGNS NEW CONTRACT FOR STREAMLINE HEALTH® eVALUATOR™
Streamline Health® Reports First Quarter 2020 Financial Results Read more about Streamline Health® Reports First Quarter 2020 Financial Results
